Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How Has the Stem Cell Therapy Market Size Evolved Over the Last Few Years?
There has been a significant expansion in the stem cell therapy market lately. This market is projected to escalate from $7.86 billion in 2024 to $9.26 billion in 2025, with a compound annual growth rate (CAGR) of 17.7%. The historic growth of this market is due to factors such as the increasing incidence of chronic diseases, enhanced funding from both governmental and private bodies, the swift development in emerging markets, higher investments in cell and gene therapies, a rise in healthcare spending, and an increase in r&d expenditure in the pharmaceutical sector.
The market size for stem cell therapy is projected to experience swift expansion in the upcoming years. Its anticipated growth values stand at $14.6 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. The factors contributing to this growth within the predicted time frame include heightened government support, an escalating elderly population, increased expenditure in healthcare and research and development. As we look towards the future, there are key market trends to take note of. These include keeping abreast with the progress in mesenchymal stem cell therapy to leverage new innovations, building strategic partnerships or acquisitions with other businesses to further bolster product innovation and boost revenue, consideration towards the development of ipsc-derived nk cells for treatment purposes, an emphasis on the enhancement of stem cell therapy particularly against cancer to outpace somatic cell competitors, and the need for companies involved in this market to integrate artificial intelligence to augment product quality, safety and production efficiency.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Are the Key Drivers Fueling Growth in the Stem Cell Therapy Market?
The escalation in the occurrence of chronic diseases has fueled the growth of the stem cell therapy market. Excessive working hours, lack of physical exercise, and unhealthy dietary routines lead to a higher incidence of chronic diseases in people, thereby necessitating the need for stem cell therapy. A United Nations report suggests that by 2030, chronic diseases are anticipated to account for 70% of all deaths worldwide. The global impact of chronic diseases is projected to surge to approximately 60%.
These growing incidences of chronic diseases are predicted to propel the market growth for stem cell therapy.
Which Key Segments Are Driving Growth in the Stem Cell Therapy Market?
The stem cell therapy market covered in this report is segmented –
1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others
4) By End-Users: Hospitals And Clinics, Research Centers, Others.
Subsegments:
1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells
2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Emerging Trends Will Impact the Stem Cell Therapy Market in the Forecast Period?
Strategic collaborations are on the rise among firms in the stem cell treatment market. Such collaborations typically involve alliances between two non-competing companies for mutual benefit. For example, in May 2022, SQZ Biotechnologies, a biotechnological company rooted in the USA, initiated a partnership with STEMCELL Technologies Inc., a biotech company from Canada. The objective of their partnership is to develop and bring to market a research-use-only (RUO) microfluidic intracellular delivery platform, which leverages SQZ’s exclusive Cell Squeeze technology. This partnership aims to equip the life science sector with improved capabilities for cell engineering for preclinical research. The collaboration will be presenting substantial findings on the effectiveness of the RUO system in efficiently transporting cargoes to primary immune cells. It will also elaborate on advancements made in cell engineering using mRNA and CRISPR/Cas9 in the domain of hematopoietic stem cells.
Which Geographies Are Leading the Expansion of the Stem Cell Therapy Market?
North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Stem Cell Therapy Market in 2025?
Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=3399
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
